Patent application number | Description | Published |
20130344504 | NNMT AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) - An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein NNMT in said sample in vitro. | 12-26-2013 |
20130344505 | APEX1 AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) - An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein APEX1 in said sample in vitro. | 12-26-2013 |
20130344506 | SEPRASE AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) - An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein Seprase in said sample in vitro. | 12-26-2013 |
20130344516 | ARMET AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) - An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein ARMET in said sample in vitro. | 12-26-2013 |
20140004543 | ASC AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | 01-02-2014 |
20140004544 | FEN1 AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | 01-02-2014 |
20140219998 | ARMET AS A MARKER FOR CANCER - Disclosed is a method aiding in the assessment of cancer. More specifically disclosed is the use of the arginine-rich metastasized in early tumors protein (=ARMET) as a universal marker of different cancer types. ARMET aids in the assessment of pulmonary or lung cancer (LC) or of colon cancer, e.g., of non-small cell lung carcinoma (NSCLC) or colorectal cancer (CRC), but also likely of other specific types of cancer. Such specific cancer types are, e.g., breast, ovary, cervix, head and neck, endometrium, melanoma, bladder, kidney, pancreas, prostate, esophagus, stomach or bile duct cancer. Further disclosed is a method for assessing cancer from a liquid sample, derived from an individual by measuring ARMET in the sample. Measurement of ARMET can, e.g., be used in the early detection of cancer or in the surveillance of patients who undergo surgery. | 08-07-2014 |
20150056642 | ARMET AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) - An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein ARMET in said sample in vitro. | 02-26-2015 |
20150072355 | FLAP ENDONUCLEASE-1 AS A MARKER FOR CANCER - Methods aiding in the assessment of cancer comprising use of the Flap endonuclease-1 protein (=FEN1) as a universal marker of different cancer types are provided. In particular, methods for assessing cancer from a liquid sample derived from an individual, which comprise measuring FEN1 in the sample are disclosed. Measurement of FEN1 is useful for the early detection of cancer or in the monitoring of patients who undergo surgery for tumor removal. | 03-12-2015 |
Patent application number | Description | Published |
20110212465 | ARMET AS A MARKER FOR CANCER - Disclosed is a method aiding in the assessment of cancer. More specifically disclosed is the use of the arginine-rich metastasized in early tumors protein (=ARMET) as a universal marker of different cancer types. ARMET aids in the assessment of pulmonary or lung cancer (LC) or of colon cancer, e.g., of non-small cell lung carcinoma (NSCLC) or colorectal cancer (CRC), but also likely of other specific types of cancer. Such specific cancer types are, e.g., breast, ovary, cervix, head and neck, endometrium, melanoma, bladder, kidney, pancreas, prostate, esophagus, stomach or bile duct cancer. Further disclosed is a method for assessing cancer from a liquid sample, derived from an individual by measuring ARMET in the sample. Measurement of ARMET can, e.g., be used in the early detection of cancer or in the surveillance of patients who undergo surgery. | 09-01-2011 |
20120196303 | CYBP AS A MARKER FOR LUNG CANCER - The present invention relates to the assessment of lung cancer. It discloses the use of protein CYBP in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring CYBP in said sample. Measurement of CYBP can, e.g., be used in the early detection or in the follow-up of patients with lung cancer. | 08-02-2012 |
Patent application number | Description | Published |
20090016161 | Method and System for Real-time Automated Change Detection and Classification for Images - A computer based system and method for real-time display of co-registered historical and current side scan sonar imagery during a side scan sonar survey. Embodiments also include modules for detection of clutter in the current imagery, identification of features, extraction of snippets, filtering based on predetermined size and shape parameters, and determination if a current feature is the same as a previously identified contact from historical imagery. | 01-15-2009 |
20120069709 | METHOD AND SYSTEM FOR REAL-TIME AUTOMATED CHANGE DETECTION AND CLASSIFICATION FOR IMAGES - A computer based system and method for real-time display of co-registered historical and current side scan sonar imagery during a side scan sonar survey. Embodiments also include modules for detection of clutter in the current imagery, identification of features, extraction of snippets, filtering based on predetermined size and shape parameters, and determination if a current feature is the same as a previously identified contact from historical imagery. | 03-22-2012 |
20120069710 | Method and System for Real-time Automated Change Detection and Classification for Images - A computer based system and method for real-time display of co-registered historical and current side scan sonar imagery during a side scan sonar survey. Embodiments also include modules for detection of clutter in the current imagery, identification of features, extraction of snippets, filtering based on predetermined size and shape parameters, and determination if a current feature is the same as a previously identified contact from historical imagery. | 03-22-2012 |